Global Insomnia Therapeutics Market Size & Outlook
Global insomnia therapeutics market, 2018-2030 (US$M)
Related Markets
Global insomnia therapeutics market highlights
- The global insomnia therapeutics market generated a revenue of USD 2,892.6 million in 2024 and is expected to reach USD 3,737.4 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 4.5% by 2030.
- In terms of segment, benzodiazepines accounted for a revenue of USD 879.1 million in 2024.
- Benzodiazepines is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 2,892.6 million |
| Market revenue in 2030 | USD 3,737.4 million |
| Growth rate | 4.5% (CAGR from 2025 to 2030) |
| Largest segment | Benzodiazepines |
| Fastest growing segment | Benzodiazepines |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists |
Other key industry trends
- In terms of revenue, the North America accounted for 35.4% of the global insomnia therapeutics market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Mexico is the fastest growing regional market and is projected to reach USD 37.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Insomnia Therapeutics Market Scope
Insomnia Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Ebb Therapeutics | View profile | 1-10 | Pittsburgh, Pennsylvania, United States, North America | https://ebbsleep.com/ |
| Vanda Pharmaceuticals | View profile | 251-500 | Washington, District of Columbia, United States, North America | http://www.vandapharma.com |
| Mylan N.V. | View profile | - | - | - |
| Sumitomo Pharma Co Ltd | View profile | 6250 | 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, Japan, 541-0045 | https://www.sumitomo-pharma.com |
| Paratek Pharmaceuticals | View profile | 251-500 | Boston, Massachusetts, United States, North America | http://paratekpharma.com/ |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Global insomnia therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to insomnia therapeutics market will help companies and investors design strategic landscapes.
Benzodiazepines was the largest segment with a revenue share of 30.39% in 2024. Horizon Databook has segmented the Global insomnia therapeutics market based on benzodiazepines, nonbenzodiazepines, antidepressants, orexin antagonists, melatonin antagonists covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Insomnia Therapeutics Type Outlook (Revenue, USD Million, 2018-2030)
- Antidepressants
- Orexin Antagonists
- Melatonin Antagonists
- Others
- Benzodiazepines
- Nonbenzodiazepines
- Global Insomnia Therapeutics Sales Channel Outlook (Revenue, USD Million, 2018-2030)
- Prescription
- Over-the-Counter (OTC)
Reasons to subscribe to Global insomnia therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global insomnia therapeutics market databook
-
Our clientele includes a mix of insomnia therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global insomnia therapeutics market , including forecasts for subscribers. This global databook contains high-level insights into Global insomnia therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global insomnia therapeutics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Insomnia therapeutics market size, 2024 (US$M)
Global insomnia therapeutics market share, by sales channel, 2024 & 2030 (%, US$M)
Insomnia therapeutics market: Opportunity assessment by country
Global insomnia therapeutics market, by region, 2024 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
